Delivery Order SPE2DB22D3019-SPE2DB26FK2UB
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,922.90 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This competitively awarded contract, issued on November 5, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order valued at $11,573.95 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designation. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order valued at $10,594.36 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under the company's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order on November 4, 2025, by the Defense Logistics Agency for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a competitively awarded, firm fixed-price delivery order with a ceiling value of $15,222.77 and an ultimate completion date of November 5, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,349.17 by the Defense Logistics Agency on September 9, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is not set-aside and was competitively awarded with a firm fixed price structure and an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $12,017.65 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $27,040.46 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,789.92 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of October 31, 2025. This non-competitive delivery order represents a firm fixed-price purchase of specialty pharmaceutical products under the company's existing contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $4,165.68 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed price delivery under a non-competitive set-aside arrangement and is scheduled for completion by July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and holds a substantial $999.999 billion...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,340.28 by the Defense Logistics Agency on August 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by August 5, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB26FK2UBDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,017.61 on November 5, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract utilizes firm fixed pricing with no set-aside designation and is expected to be completed by November 6, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX that runs through December 2026 and serves as a comprehensive global pharmaceutical support platform for military healthcare systems worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor specializing in federal medical procurement for military and veteran healthcare systems. The company maintains an extensive portfolio of delivery orders through the DLA Medical Supply Chain covering a wide range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This particular delivery order for Repatha—a PCSK9 inhibitor indicated for high cholesterol treatment—reflects the company's role in supplying critical specialty pharmaceuticals to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 11/5/25 |